Diclofenac Topical vs Low-Dose Naltrexone (LDN)
A side-by-side research comparison of Diclofenac Topical and Low-Dose Naltrexone (LDN) across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Diclofenac Topical | Low-Dose Naltrexone (LDN) |
|---|---|---|
| Full name | Diclofenac Sodium Topical Gel (Voltaren) | Low-Dose Naltrexone |
| Category | Pain & Inflammation | Pain & Inflammation |
| Status | FDA Approved (OTC) | Off-label prescription |
| Mechanism | Inhibits cyclooxygenase-1 and -2 (COX-1/2) locally in tissue, reducing prostaglandin E2 synthesis at the inflammation site. Topical delivery achieves therapeutic tissue concentrations with plasma levels <5% of oral dosing. | Brief nocturnal opioid receptor blockade triggers compensatory upregulation of endogenous opioid production and OGF (opioid growth factor), modulating immune cell proliferation and reducing inflammatory cytokines. |
| Molecular weight | 318.13 Da (sodium salt) | 341.40 Da |
| Half-life | ~1-2 hours (plasma); tissue penetration lasts 12+ hours | ~4 hours |
| Bioavailability | ~6% systemic (topical); local tissue levels therapeutic | ~5-40% oral (first-pass) |
| Typical dose | 4g gel (1% or 2%) per joint | 1.5-4.5 mg |
| Frequency | 3-4x daily | Nightly at bedtime |
| Route | Topical gel | Oral capsule (compounded) |
Diclofenac Topical reported benefits
- Localized pain relief
- Minimal systemic side effects
- Joint and tendon inflammation
- Post-workout recovery
- No GI ulcer risk
- OTC availability
Low-Dose Naltrexone (LDN) reported benefits
- Immune modulation
- Reduced inflammation
- Chronic pain relief
- Autoimmune support
- Improved mood via endorphins
- Weight loss support
Related comparisons
Research and educational reference only. Not medical advice.